This is a patent covering the de-immunization of an organ by treatment with TGF-b before transplantation. The organs that may be used include heart, liver, spleen, pancreas, thyroid lobe, lung, kidney, intestine, blood vessel, and esophagus. The use of TGF bet to decrease immunogenecity is supported by other observations that this...
This patent teaches the use of stem cells derived from amniotic tissue for regeneration of cartilage tissue. The stem cells of the amniotic tissue claimed are epithelial and free of mesenchymal tissue.
This patent teaches that embryonic yolk sac, midbrain, and forbrain cells may be gene transfected with a useful gene and utilized as a vector for delivery of the gene to an area of need.
This is a patent on ways of generating a cytokine called human p-G-CSF. I wonder what the modern name of this cytokine is? In any case, the invention teaches that this cytokine stimulates hematopoietic stem cells proliferation.
Like other hematopoietic cytokines, this patent teaches that hpG-CSF may be administered for the treatment of burn wounds.
This patent covers the use of human pluripotent granulocyte colony stimulating factor for induction of granulocyte production, as well as for reducing bacterially mediated inflammation. The use of growth factors such as the one described has expanded in recent years to other types of stem cells besides hematopoietic stem cells. It will be interesting to see first what the new name for the...